Advertisement

Pulmonology

Risk Factors ID'd for New Long-Term Opioid Use After Lung Cancer Surgery

Sep 14, 2022

TUESDAY, Sept. 13, 2022 (HealthDay News) -- Potential risk factors for new long-term opioid use after lung cancer surgery have been identified, and new long-term opioid use is associated with an incre...

Biden Makes Another Push for Cancer Moonshot Initiative

Sep 14, 2022

TUESDAY, Sept. 13, 2022 (HealthDay News) -- President Joe Biden made a renewed push for his cancer moonshot initiative on Monday.Speaking at the famed John F. Kennedy Presidential Library and Museum i...

OOP Costs for Cancer Treatments Increased From 2009 to 2016

Sep 14, 2022

TUESDAY, Sept. 13, 2022 (HealthDay News) -- The costs of cancer treatments increased from 2009 to 2016, with a corresponding increase in out-of-pocket (OOP) costs for privately insured nonelderly adul...

Home oxygen therapy for bronchiolitis feasible, cost-effective, and favorable to caregivers

Sep 13, 2022

1. A systematic review of international literature suggests that home oxygen therapy for bronchiolitis is well-received by parents and caregivers and can reduce hospital costs. 2. Available evidence, ...

Spirometry Accuracy for Genetically Admixed Children

Sep 13, 2022

A need exists for personalized, genetic ancestry-informed respiratory equations for predicting an individual’s lung function. Guideline-recommended spirometry reference equations, which rely ...

Factors associated with greater severity of COVID-19 disease among solid transplant recipients

Sep 09, 2022

1. For solid organ transplant recipients with symptomatic COVID-19, factors associated with increased requirement of supplemental oxygen include older age, greater number of comorbid conditions, highe...

FVC & Airway Dysfunction Linked With Poor Asthma Control

Sep 08, 2022

Patients with asthma who had combined impairment of both forced vital capacity and area under the reactance curve had notably worse asthma control. Standard care for severe asthma aims to prese...

Air Pollution Increases Heart Attacks in Nonsmokers

Sep 07, 2022

TUESDAY, Sept. 6, 2022 (HealthDay News) -- Air pollution is associated with significant increases in heart attacks among nonsmokers, according to a study presented at the European Society of Cardiolog...

Bronchodilator Does Not Improve Respiratory Symptoms for Tobacco-Exposed

Sep 06, 2022

TUESDAY, Sept. 6, 2022 (HealthDay News) -- For symptomatic, tobacco-exposed persons with preserved lung function, inhaled dual bronchodilator therapy does not reduce respiratory symptoms, according to...

Flu Shot Recommended for All Children ≥6 Months, Early in Season

Sep 06, 2022

TUESDAY, Sept. 6, 2022 (HealthDay News) -- In a policy statement issued by the American Academy of Pediatrics (AAP) Committee on Infectious Diseases and published online Sept. 6 in Pediatrics, recomme...

FDA Warns of Dangers From Skin-Lightening Creams

Sep 06, 2022

THURSDAY, Sept. 1, 2022 (HealthDay News) -- Skin-lightening products can be dangerous for consumers when they contain harmful ingredients that are illegal for over-the-counter sales, the U.S. Food and...

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency

Sep 06, 2022

FRIDAY, Sept. 2, 2022 (HealthDay News) -- The U.S. Food and Drug Administration has approved Xenpozyme (olipudase alfa) for pediatric and adult patients with acid sphingomyelinase deficiency (ASMD), a...

Bedaquiline-pretomanid-linezolid regimen is effective for treating drug-resistant tuberculosis

Sep 06, 2022

1. Four bedaquiline-pretomanid-linezolid treatment groups had a favorable outcome for the treatment of drug-resistant tuberculosis. 2. The treatment group with linezolid at 600mg for 26 weeks had the ...

Adjuvant erlotinib increased overall survival when compared to chemotherapy in stage IIIA EGFR-mutant non-small cell lung cancer

Sep 06, 2022

1. Erlotinib showed an overall survival benefit and improved 5-year survival rates when compared to chemotherapy. 2. Disease-free survival was significantly better in the erlotinib arm than with chemo...

Non-Small Cell Lung Cancer and Leptomeningeal Disease: Systemic Treatment Patterns and Outcomes

Sep 01, 2022

For a study, researchers sought to understand that in 9%–10% of instances of non-small cell lung cancer (NSCLC) with an EGFR mutation, leptomeningeal (LM) disease presents. Particularly in the era o...

Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT

Sep 01, 2022

For a study, researchers sought to understand that immunotherapy has significantly altered how non-small cell lung cancer (NSCLC) in advanced stages is treated. However, immunotherapy often negatively...

Study of Pembrolizumab With Concurrent Chemoradiotherapy

Sep 01, 2022

For a study, researchers sought to study that concurrent chemoradiotherapy  (CCRT) is the gold standard of treatment for persons with recently discovered limited-stage small-cell lung cancer (SCLC). ...

Lung Cancer Screening Population and Comorbidities: Prevalence and Impact

Sep 01, 2022

For a study, researchers sought to understand that lung cancer screening trials frequently enlist dedicated, motivated, and generally healthy people. They, therefore, used low-dose computed tomography...

Study Comparing Complex Segmentectomy with Wedge Resection in Stage 0-IA Non-Small Cell Lung Cancer

Sep 01, 2022

For a study, researchers sought to understand that although wedge resection and complex segmentectomy are rarely compared in the literature, sublobar resection is a common treatment for lung cancer. T...

Non-Small Cell Lung Cancer Missed Diagnosis and Chest Imaging

Sep 01, 2022

For a study, researchers sought to understand that medical-legal action against persons believed to have missed the initial diagnosis may be taken if a chest lesion was discovered on imaging tests bef...